Hvis Kivexa seponeres hos patienter, som samtidigt er inficeret med hepatitis B virus, anbefales periodisk monitorering af både leverfunktionsprøver og markører for HBV- replikation, da seponering af lamivudin kan resultere i akut tilbagevenden af hepatitis (se produktresumeet for Zeffix).
If Kivexa is discontinued in patients co-infected with hepatitis B virus, periodic monitoring of both liver function tests and markers of HBV replication is recommended, as withdrawal of lamivudine may result in an acute exacerbation of hepatitis (see Zeffix SPC).